UPMC Hillman Cancer Center is part of the UPMC family.

5_research_clinicaltrials

Clinical Trials

UPMC Hillman Cancer Center conducts research to advance our understanding of cancer.

Our cancer researchers work with clinicians to quickly move the most promising research results from their labs into clinical trials. This gives you early access to new and innovative cancer treatments throughout our UPMC Hillman Cancer Center network.

For more than 30 years, our commitment to excellence in all aspects of cancer care has led to many life-changing efforts.

And, we continue to:

Our end goal is to reduce the burden of this disease and improve cancer treatment.

Patient IV

The Value of Taking Part in a Clinical Trial

Clinical trials are incredibly valuable to both researchers and patients. Investigators use clinical trials to test new drugs and therapies that treat a wide range of human cancers.

Learn more from UPMC HealthBeat.

Download the UPMC Hillman Cancer Trials Finder App.

UPMC Hillman Cancer Trials Finder

Get the latest updates about more than 500 UPMC Hillman clinical trials right on your smartphone or tablet with UPMC Hillman Cancer Trials Finder. Available for both Android and iOS platforms.

Download on the App Store
Download on Google Play


Browse our current clinical trials and research studies below. Or, see our online resources for cancer research and clinical trials at UPMC Hillman Cancer Center.

For more details about a clinical trial, please e-mail CTMAMobileApp@upmc.edu

Search Clinical Trials

Cancer Type

Begin typing a cancer type and then select from the suggestion list provided

Keyword

Enter a keyword to search clinical trial long title, short titles, HCC Number and physician information

Cancer Stage (Select any that apply)

Treatment Line (Select any that apply)

Eligibility Criteria

Enter keyword(s) to search within inclusion criteria

Enter keyword(s) to search within exclusion criteria

Search Results

  • We found no results matching your search. Please ensure that your spelling is correct or try broadening your search.